Subgroup analysis reveals ongoing symptom burden in satisfied narcolepsy patients, suggesting further investigation is needed.
To analyze residual symptom burden in a subgroup of respondents from the CRESCENDO survey of patients with narcolepsy type 1 (NT1) who reported satisfaction with their current narcolepsy medication.
No takes yet. Share an insight, caveat, or question.
Thorpy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: